What is the share price of Unichem Laboratories Ltd (UNICHEMLAB) today?
The share price of UNICHEMLAB as on 26th March 2025 is ₹688. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Unichem Laboratories Ltd (UNICHEMLAB) share?
The past returns of Unichem Laboratories Ltd (UNICHEMLAB) share are- Past 1 week: 8.06%
- Past 1 month: 7.18%
- Past 3 months: -1.79%
- Past 6 months: 6.97%
- Past 1 year: 40.68%
- Past 3 years: 179.99%
- Past 5 years: 537.66%
What are the peers or stocks similar to Unichem Laboratories Ltd (UNICHEMLAB)?
The peers or stocks similar to Unichem Laboratories Ltd (UNICHEMLAB) include:What is the market cap of Unichem Laboratories Ltd (UNICHEMLAB) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Unichem Laboratories Ltd (UNICHEMLAB) is ₹4821.74 Cr as of 26th March 2025.What is the 52 week high and low of Unichem Laboratories Ltd (UNICHEMLAB) share?
The 52-week high of Unichem Laboratories Ltd (UNICHEMLAB) is ₹937.95 and the 52-week low is ₹472.75.What is the PE and PB ratio of Unichem Laboratories Ltd (UNICHEMLAB) stock?
The P/E (price-to-earnings) ratio of Unichem Laboratories Ltd (UNICHEMLAB) is -68.42. The P/B (price-to-book) ratio is 2.04.Which sector does Unichem Laboratories Ltd (UNICHEMLAB) belong to?
Unichem Laboratories Ltd (UNICHEMLAB) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Unichem Laboratories Ltd (UNICHEMLAB) shares?
You can directly buy Unichem Laboratories Ltd (UNICHEMLAB) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Unichem Laboratories Ltd
UNICHEMLAB Share Price
688.000.94% (-6.55)
UNICHEMLAB Share Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
UNICHEMLAB Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -128.27 | 2.04 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 49.27 | 6.30 | 0.54% |
UNICHEMLAB Analyst Ratings & Forecast
Detailed Forecast —
Forecast data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
UNICHEMLAB Company Profile
Unichem Laboratories Limited is a pharmaceutical company that manufactures active pharmaceutical ingredients (APIs or bulk actives).
UNICHEMLAB Similar Stocks (Peers)
Compare with peersSUNPHARMA
PE Ratio
44.07
1Y Return
10.07%
Buy Reco %
88.24
CIPLA
PE Ratio
28.93
1Y Return
0.27%
Buy Reco %
72.73
TORNTPHARM
PE Ratio
65.78
1Y Return
25.23%
Buy Reco %
68.00
MANKIND
PE Ratio
51.84
1Y Return
6.81%
Buy Reco %
80.00
DRREDDY
PE Ratio
17.40
1Y Return
5.08%
Buy Reco %
45.16
UNICHEMLAB Forecasts
Price
Revenue
Earnings
UNICHEMLAB Share Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeUNICHEMLAB Company Revenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeUNICHEMLAB Stock EPS (Earnings Per Share) Forecast
Hmm, looks like data is unavailable here. Please come back after some timeUNICHEMLAB
Income
Balance Sheet
Cash Flow
Annual Normal View
UNICHEMLAB Income Statement
Annual Normal View
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,351.39 | 882.81 | 3,553.47 | 1,280.29 | 1,195.84 | 1,285.33 | 1,317.34 | 1,381.54 | 1,804.50 | 1,950.90 | ||||||||||
Raw Materials | 476.53 | 262.42 | 387.73 | 477.13 | 422.92 | 467.52 | 457.36 | 533.73 | 743.72 | 1,834.35 | ||||||||||
| Power & Fuel Cost | 38.25 | 41.62 | 49.23 | 76.39 | 73.02 | 68.89 | 78.05 | 102.84 | 107.14 | |||||||||||
| Employee Cost | 255.92 | 169.04 | 200.64 | 238.52 | 273.28 | 306.97 | 330.49 | 356.41 | 393.06 | |||||||||||
| Selling & Administrative Expenses | 380.90 | 233.92 | 291.18 | 420.94 | 345.54 | 316.35 | 287.13 | 299.84 | 361.41 | |||||||||||
| Operating & Other expenses | 20.69 | 32.10 | 17.93 | 50.56 | 39.77 | -15.36 | 45.07 | 134.33 | 124.94 | |||||||||||
EBITDA | 179.10 | 143.71 | 2,606.76 | 16.75 | 41.31 | 140.96 | 119.24 | -45.61 | 74.23 | 116.55 | ||||||||||
| Depreciation/Amortization | 38.79 | 43.52 | 50.51 | 67.37 | 81.67 | 84.36 | 91.17 | 113.44 | 113.24 | 118.29 | ||||||||||
| PBIT | 140.31 | 100.19 | 2,556.25 | -50.62 | -40.36 | 56.60 | 28.07 | -159.05 | -39.01 | -1.74 | ||||||||||
| Interest & Other Items | 2.90 | 3.36 | 8.01 | 7.52 | 7.85 | 5.12 | 6.11 | 17.31 | 22.66 | 20.16 | ||||||||||
| PBT | 137.41 | 96.83 | 2,548.24 | -58.14 | -48.21 | 51.48 | 21.96 | -176.36 | -61.67 | -21.90 | ||||||||||
| Taxes & Other Items | 29.30 | -11.85 | 3.34 | -34.35 | 11.97 | 17.15 | -11.09 | 25.86 | 8.80 | 15.69 | ||||||||||
| Net Income | 108.11 | 108.68 | 2,544.90 | -23.79 | -60.18 | 34.33 | 33.05 | -202.22 | -70.47 | -37.59 | ||||||||||
| EPS | 11.91 | 11.96 | 315.72 | -3.38 | -8.55 | 4.88 | 4.69 | -28.72 | -10.01 | -5.34 | ||||||||||
| DPS | 2.00 | 3.00 | 5.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.17 | 0.25 | 0.02 | — | — | 0.82 | 0.85 | — | 0.00 | 0.00 |
UNICHEMLAB Company Updates
FY 2015
Annual report
PDFFY 2018
Annual report
PDFFY 2019
Annual report
PDFFY 2020
Annual report
PDFFY 2021
Annual report
PDFFY 2022
Annual report
PDFFY 2023
Annual report
PDFFY 2024
Annual report
PDFUNICHEMLAB Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Unichem Laboratories Ltd | -68.42 | 2.04 | — |
| Sun Pharmaceutical Industries Ltd | 44.07 | 6.29 | 0.77% |
| Cipla Ltd | 28.93 | 4.45 | 0.88% |
| Torrent Pharmaceuticals Ltd | 65.78 | 15.89 | 0.87% |
UNICHEMLAB Stock Price Comparison
Compare UNICHEMLAB with any stock or ETFCompare UNICHEMLAB with any stock or ETF
UNICHEMLAB
UNICHEMLAB Shareholdings
UNICHEMLAB Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
UNICHEMLAB Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
UNICHEMLAB Shareholding Pattern
UNICHEMLAB Shareholding History
Foreign Institutions
Mutual Funds Invested in UNICHEMLAB
A list of mutual funds holding the stock, ranked on the basis of Market-cap held which is calculated as the value of stock held in the portfolio divided by its market cap
Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Unichem Laboratories Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 6.7709% | Percentage of the fund’s portfolio invested in the stock 1.18% | Change in the portfolio weight of the stock over the last 3 months -0.18% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 58/90 (-34) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.0439% | Percentage of the fund’s portfolio invested in the stock 1.73% | Change in the portfolio weight of the stock over the last 3 months -0.17% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 20/34 (-1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.4106% | Percentage of the fund’s portfolio invested in the stock 0.36% | Change in the portfolio weight of the stock over the last 3 months -0.41% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 27/70 (0) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing UNICHEMLAB stock
Looks like this stock is not in any smallcase yet.
UNICHEMLAB Events
UNICHEMLAB Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
UNICHEMLAB Upcoming Dividends
No upcoming dividends are available
UNICHEMLAB Past Dividends
Cash Dividend
Ex DateEx DateAug 1, 2022
Final
Final | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
Aug 1, 2022
Cash Dividend
Ex DateEx DateJul 22, 2021
Final
Final | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
Jul 22, 2021
Cash Dividend
Ex DateEx DateAug 20, 2020
Final
Final | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
Aug 20, 2020
Cash Dividend
Ex DateEx DateJul 18, 2019
Final
Final | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
Jul 18, 2019
Cash Dividend
Ex DateEx DateJul 19, 2018
Final
Final | Div/Share: ₹5.00
Dividend/Share
₹5.00
Ex DateEx Date
Jul 19, 2018
UNICHEMLAB Stock News & Opinions
Articles & Videos
Corporate
Unichem Laboratories receives update in credit ratings from ICRA
Unichem Laboratories announced that t ICRA, the credit rating agency has upgraded the rating to [ICRA] A+ from [ICRA] A assigned earlier to the Rs. 180.0 crore bank facilities of the Company. Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Unichem Laboratories consolidated net profit declines 20.99% in the December 2024 quarter
Net profit of Unichem Laboratories declined 20.99% to Rs 57.85 crore in the quarter ended December 2024 as against Rs 73.22 crore during the previous quarter ended December 2023. Sales rose 14.47% to Rs 533.09 crore in the quarter ended December 2024 as against Rs 465.72 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales533.09465.72 14 OPM %16.046.68 - PBDT92.3936.81 151 PBT61.855.19 1092 NP57.8573.22 -21 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Unichem Laboratories schedules board meeting
Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 6 February 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Unichem Laboratories reports consolidated net profit of Rs 30.49 crore in the September 2024 quarter
Net profit of Unichem Laboratories reported to Rs 30.49 crore in the quarter ended September 2024 as against net loss of Rs 24.49 crore during the previous quarter ended September 2023. Sales rose 11.20% to Rs 462.16 crore in the quarter ended September 2024 as against Rs 415.63 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales462.16415.63 11 OPM %12.452.11 - PBDT61.537.57 713 PBT32.99-21.88 LP NP30.49-24.49 LP Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Unichem Laboratories to discuss results
Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Unichem Laboratories to hold board meeting
Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 30 September 2024.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Board of Unichem Laboratories to consider proposal for consolidation of generic formulations biz in US
The Board of Unichem Laboratories will meet on 30 September 2024 to consider and approve integration and consolidation of the generics formulations business in the US market of M/s. Bayshore Pharmaceuticals LLC (wholly owned subsidiary of Company's holding company, Ipca Laboratories) into Unichem Pharmaceuticals (USA) Inc. (company's wholly owned subsidiary) so as to consolidate all the Ipca Group's USA generics formulations business under one entity.Powered by Capital Market - Live
6 months agoCapital Market - Live
Spotlight
Unichem Labs gains on proposal to consolidate USA generics formulations business under one entity
In an exchange filing made before market hours today, the company said that its board will consider integration and consolidation of the generics formulations business in the US market of Bayshore Pharmaceuticals LLC into Unichem Pharmaceuticals (USA) Inc. so as to consolidate all the Ipca Group's USA generics formulations business under one entity. Bayshore Pharmaceuticals LLC is a wholly owned subsidiary of Unichem's holding company Ipca Laboratories. Unichem Pharmaceuticals (USA) Inc. is the wholly owned subsidiary of Unichem Labs. Unichem Laboratories is a pharmaceutical company. It addresses the needs of therapeutic areas like gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterials, anti-infectives and pain management. The company had reported a consolidated net profit of Rs 9.26 crore in the quarter ended June 2024 as against net loss of Rs 0.67 crore during the previous quarter ended June 2023. Sales rose 5.49% to Rs 446.43 crore in Q1 FY25 over Q1 FY24. Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Board of Unichem Laboratories appoints CFO
The Board of Unichem Laboratories at its meeting held on 08 August 2024 has approved appointment of Sanjay Jain as the Chief Financial Officer and Key Managerial Personnel of the Company with effect from 8 August 2024. Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Unichem Laboratories reports consolidated net profit of Rs 9.26 crore in the June 2024 quarter
Net profit of Unichem Laboratories reported to Rs 9.26 crore in the quarter ended June 2024 as against net loss of Rs 0.67 crore during the previous quarter ended June 2023. Sales rose 5.49% to Rs 446.43 crore in the quarter ended June 2024 as against Rs 423.19 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales446.43423.19 5 OPM %9.746.62 - PBDT43.3330.89 40 PBT15.002.12 608 NP9.26-0.67 LP Powered by Capital Market - Live
7 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 7.1%, vs industry avg of 9.04%
Over the last 5 years, market share decreased from 0.58% to 0.47%